What Are The Chances Of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NASDAQ listed company, PHAT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Phathom Pharmaceuticals Inc is $741.90M. A total of 0.56 million shares were traded on the day, compared to an average of 646.63K shares.

In the most recent transaction, Nabulsi Azmi sold 10,901 shares of PHAT for 11.72 per share on Jul 15 ’24. After the transaction, the Chief Operating Officer now owns 240,421 company shares. In a previous transaction on Jul 15 ’24, Henderson Molly sold 4,325 shares at 11.72 per share. PHAT shares that CFO and CBO owns now total 99,447.

Among the insiders who sold shares, Curran Terrie disposed of 33,848 shares on Jul 15 ’24 at a per-share price of $11.72. This resulted in the President and Chief Executive holding 377,734 shares of PHAT after the transaction. In another insider transaction, Henderson Molly sold 3,435 shares at $11.10 per share on Apr 08 ’24. Company shares held by the CFO and CBO now total 95,263.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, PHAT has a high of $15.56 and a low of $6.07.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PHAT is Buy with a score of 4.57.

Most Popular

Related Posts